This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Diabetes Mellitus, Type 2 or Obesity
and you are
between 20 and 75
years old
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

This is a prospective, randomized clinical trial for patients with recurrent type 2 diabetes post-gastric bypass surgery that will compare a 6 month course of canagliflozin monotherapy vs. placebo on clinical outcomes of type 2 diabetes.

Provided treatments

  • Drug: canagliflozin
  • Drug: Placebo (for canagliflozin)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02912455. The sponsor of the trial is The Cleveland Clinic and it is looking for 16 volunteers for the current phase.
Official trial title:
Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes